Background: In asthma, fluticasone-furoate/umeclidinium/vilanterol (FF/UMEC/VI) was previously demonstrated to improve FEV1and asthma-control, but the mechanism by which this occurs, especially at the level of the small-airways, is not well-understood. We asked the question, does FF/UMEC/VI influence asthma-control by improving airway structure-function and airway occlusions? Hence, here our objective was to measure airway structure-function using129Xe MRI ventilation-defect-percent (VDP), CT and airwave-oscillometry after 6-weeks single-inhaler FF/UMEC/VI and 1-year later.Methods: Participants with GINA4-5 asthma who were poorly controlled on inhaled-corticosteroid/long-acting-bronchodilator (ICS/LABA), provided written-informed-consent to baseline, 6-, and 12-week visits as well as an open-extension 1-year visit. All received FF/UMEC/VI (200/62.5/25 µg) at baseline and underwent MRI, spirometry, plethysmography and oscillometry, pre- and post-bronchodilator (BD). Asthma-control (ACQ-6), asthma-quality-of-life (AQLQ) and St. George's Respiratory-Questionnaire (SGRQ) were completed. CT was acquired at baseline and 1-year later.Results: Thirty-one participants (24 females, 54±15 yrs) completed baseline, 28 (21 females, 54±15 yrs) completed the 6-week and 15 patients attended the 1-year visit. At 6-weeks, there was significantly improved pre-BD VDP (p=.02), FEV1(p=.008), distal-airways-resistance (R5–19; p=.001), AQLQ (p<.001) and SGRQ-scores (p=.001), which persisted at 1-year. VDP improved in participants with elevated mucus-score and eosinophil-count, while R5–19improvements were independent of type-2 inflammation. Mean airway mucus-score, lumen-area and total-airway-count were significantly improved at 1-year.Conclusions: In participants with GINA4-5 asthma, who had been poorly controlled on ICS/LABA, single-inhaler FF/UMEC/VI resulted in improved VDP and FEV1at 6-weeks. These improvements persisted 1-year later when airway markers were also significantly improved, consistent with the reversal of airway remodeling.